Position in ABBV
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,323,209
-$216,932 QoQ
Shares Held
25,128
-16.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#1,172
of 4,153 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Applied Finance Capital Management, LLC holds $53,647,387 across 10 Drug Manufacturers - General names. ABBV ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
133,454 | $17,148,839 | |
| 2 | LLY |
ELI LILLY & Co
|
12,549 | $15,051,648 | |
| 3 | JNJ |
Johnson & Johnson
|
25,604 | $6,502,647 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
25,128 | $6,323,209 | |
| 5 | AMGN |
Amgen Inc
|
6,845 | $2,478,711 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
35,950 | $2,071,439 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
14,693 | $1,856,313 | |
| 8 | NVS |
Novartis AG
|
6,260 | $981,067 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,323,209 | 25,128 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,540,141 | 30,071 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,830,480 | 29,894 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,782,458 | 20,655 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,121,692 | 22,205 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $5,158,591 | 24,621 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $3,907,445 | 21,989 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,660,133 | 23,598 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,455,613 | 20,147 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $348,357 | 1,913 | Shares | Sole | 2024-05-07 | |
| No filing history on record for this holder in this stock. | ||||||